11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment - Wikidata - wikimedia - TriplyDB

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

http://www.wikidata.org/entity/Q24648319

about

Measuring the characteristic topography of brain stiffness with magnetic resonance elastography Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients 11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementia Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Brain investigation and brain conceptualization MR-less surface-based amyloid assessment based on 11C PiB PET Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo Biomarkers of Alzheimer's disease What can imaging tell us about cognitive impairment and dementia?Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions PET and MR imaging: the odd couple or a match made in heaven?Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease Brain PET in the diagnosis of Alzheimer's disease Development of positron emission tomography β-amyloid plaque imaging agents Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech.Neuroimaging biomarkers of neurodegenerative diseases and dementia Beta-amyloid deposition and the aging brain Prediction of cognitive decline in healthy older adults using fMRI Validation of the Face Name Associative Memory Exam in cognitively normal older individuals Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials Differences in functional brain connectivity alterations associated with cerebral amyloid deposition in amnestic mild cognitive impairment The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers Regional brain stiffness changes across the Alzheimer's disease spectrum Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.Preoperative assessment of meningioma stiffness using magnetic resonance elastography.Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography Disruption of functional connectivity in clinically normal older adults harboring amyloid burden.Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA.Current neuroimaging techniques in Alzheimer's disease and applications in animal models Necessity of normative data on the Japanese version of the Wechsler Memory Scale-Revised Logical Memory subtest for old-old people.Prediction of conversion from mild cognitive impairment to Alzheimer disease based on bayesian data mining with ensemble learning.

P2860

Q21558495-D7139B16-A69D-492C-ABEC-823B8370EBA6 Q22242926-B526834D-1E38-491A-B7B8-FAFB2D54BE17 Q22251259-734EF608-A2CA-4744-BD4D-355090875E3C Q24194742-7E9C155B-C177-48FE-92F4-08E5E9DEA2E8 Q24235058-2F2489B7-6E70-4B94-A317-3CF66B6ED44C Q24594531-5BC80B03-092B-47B2-B918-2548005DADD9 Q24595802-CBA27849-B6CA-4CA3-93EB-3C5CF9A3F14D Q24604341-056AF925-A7DA-4F47-A382-8142D3A1E001 Q24618963-CA3A683B-F9B3-4AE0-AE95-F2F77EDE111F Q24648007-3C7A3C75-48CC-4FCC-A618-F9DAB35B2E6B Q24650667-ACD5CB48-DC5B-4CA2-AB66-A69D68E7AA37 Q26749292-777456A1-72E5-4182-84B3-0A03A3DDBAC7 Q26749755-D2B6E80B-8807-4EAE-963D-3A71B3BE486F Q26830740-B08B1DAA-AB0A-493F-BFFB-AB5F4AD46E57 Q26851721-69DCEB14-E7E1-40C8-9B0C-85A010591F75 Q26864063-F1F283C9-85EA-4423-AD4E-04F42D085C87 Q27009411-1262CD0E-2848-4528-B602-12EA9FBCE383 Q27011549-96F2458A-EC82-4CD3-991A-5E3D1E11BEEC Q27012742-720F07C0-6DD6-47D5-BBB1-31186BBAE8BE Q27303745-D9E198B2-7793-4A59-B022-D532C7CA079D Q27317202-CBDEC04E-F4E1-424A-A92E-E8ED8D468612 Q27691820-643EF127-0420-47E8-B674-623AF580BA61 Q28264556-E786D771-A003-4300-905D-2B696079FC93 Q28383378-D444875C-B951-4E97-A933-C2B3FD834812 Q28386196-46C3C320-4084-4EF2-8274-8742268D11A1 Q28488143-12CE628F-0949-4C01-9C9D-CA590171D0EC Q28649713-3C758145-4424-492F-BC95-D37598FC4FAD Q29547554-4DECBA42-BC94-4841-906B-1A05DAFCAE8D Q29614406-4A2BB742-212D-4BB7-8388-8C9DBBEEA740 Q29614407-FBDF78A5-589C-408F-93D4-F24657EB2248 Q29620245-532EBD80-857D-45FD-A585-86453E7D0C0B Q30390749-F082120C-F713-4ED0-BD49-A5EF45EC6C95 Q30413572-C27987C9-D9D0-4A34-A15F-2553C5889737 Q30443175-1FF34EBC-80E9-43DC-9589-08D6BA1947C5 Q30464223-617FAEF3-6814-4FEF-9954-1B6D8EABF0D5 Q30492809-5425C4E6-CA21-441A-A7EB-A18F8664A27A Q30544788-1F94DBBB-8C16-4D49-872A-F694835D753E Q30576714-69627E5A-FFBA-4711-929D-1F96032A4595 Q30583805-DFA525CF-8B57-42D2-A3A9-C0B3EB8D8F8E Q30666491-5B8E7D26-7DA7-4D74-8548-0B68AE09888B

P2860

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

http://www.wikidata.org/entity/Q24648319

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

11C PiB and structural MRI pro ...... stic mild cognitive impairment

@ast

11C PiB and structural MRI pro ...... stic mild cognitive impairment

@en

11C PiB and structural MRI pro ...... stic mild cognitive impairment

@nl

type

label

11C PiB and structural MRI pro ...... stic mild cognitive impairment

@ast

11C PiB and structural MRI pro ...... stic mild cognitive impairment

@en

11C PiB and structural MRI pro ...... stic mild cognitive impairment

@nl

prefLabel

11C PiB and structural MRI pro ...... stic mild cognitive impairment

@ast

11C PiB and structural MRI pro ...... stic mild cognitive impairment

@en

11C PiB and structural MRI pro ...... stic mild cognitive impairment

@nl

P1433

Q24648319-F811B545-7C1A-4BC9-829D-66E1E85AA4A7

P1476

Q24648319-F3BF5C5E-EDFB-4190-9607-5A1C1D41DC82

P2093

Q24648319-2A7D06B5-C358-4194-A675-D6C5A0A662AA

Q24648319-324F5C18-26F3-462D-B398-9CB00AEF6A12

Q24648319-40F3EBDF-65AB-4D4A-86CB-FE25E84665C4

Q24648319-B2CF130A-8218-4790-97C9-A547E58E7844

Q24648319-C04CDE38-EF8C-4803-9673-8884E015EEB1

Q24648319-E010F409-B59E-4A00-92B6-CE9D4FE21F7F

Q24648319-EDDD534F-61B2-4DB9-8277-251959731788

P2860

Q24648319-0102CC1F-2CEF-4F2D-B9FF-C218A9EC847B

Q24648319-0144456E-7CB5-4995-AC7F-8A4324131451

Q24648319-0270F339-2FEB-4947-9445-926C5C091C2C

Q24648319-04A522EB-C3FD-4237-B32D-44BA5A92CFFF

Q24648319-08D8BE36-5438-4018-962B-BB502987D143

Q24648319-093D2C74-91E0-4EA6-ADC1-4DE7B65BA94B

Q24648319-0960AB98-FAA5-47E1-8CD8-8B33F9E5DF97

Q24648319-0C3F90BE-4F66-43A0-9E7F-183B8C683018

Q24648319-0D4A0631-CD94-4535-BDBF-0FA73D458220

Q24648319-11D68D2C-7AE1-4E0D-8CA0-054F37A5E002

P304

Q24648319-02097E57-D844-47EB-ADCF-32D3F703BD06

P31

Q24648319-EBFEBF97-7101-455A-9563-8AF88971FB70

P3181

Q24648319-6DDC281F-3288-4F2E-B8BE-1EF056B273E6

P356

Q24648319-B0F94ED6-C5F2-41E6-B73C-A3F82F03F348

P407

Q24648319-2E5E16E5-9D54-4D20-8760-8AD632181AE7

P433

Q24648319-B45FF1F5-9825-475B-B799-029061BFD5C9

P478

Q24648319-F73C1BB8-7A3E-4EC1-A10C-6FF707D030A3

P50

Q24648319-280C9B83-DFB9-4C5A-BE9F-B120B568E763

Q24648319-99880B52-58B7-4EA4-B2C1-25298F3E374B

Q24648319-DC734868-3620-455C-B7B1-A72B36D109C2

Q24648319-F6CCA8C6-9FFA-413A-A4C4-11B2A10F70C3

P577

Q24648319-26952BE8-C53F-4F44-BD18-165B434E565E

P5875

Q24648319-8493AF9B-7262-4F1C-B66C-0397C936468F

P698

Q24648319-D298C186-D433-46EE-8C18-47FC3F2BD362

P921

Q24648319-1EE703DC-CD95-47EB-B639-9F6338E6E8C1

P932

Q24648319-CD9A06EE-A32A-47D1-BC5A-CE8D192E7A7A

P3181

P356

P1433

P1476

11C PiB and structural MRI pro ...... stic mild cognitive impairment

@en

P2093

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

Bradley J Kemp

http://www.w3.org/2001/XMLSchema#string

Chester A Mathis

http://www.w3.org/2001/XMLSchema#string

Maria M Shiung

http://www.w3.org/2001/XMLSchema#string

Matthew L Senjem

http://www.w3.org/2001/XMLSchema#string

Stephen D Weigand

http://www.w3.org/2001/XMLSchema#string

Val J Lowe

http://www.w3.org/2001/XMLSchema#string

P2860

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Voxel-based morphometry--the methods

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

P304

665-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1617819

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/BRAIN/AWM336

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 3

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

William E. Klunk

Ronald C. Petersen

David S Knopman

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5587785

http://www.w3.org/2001/XMLSchema#string

P698

18263627

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2730157

http://www.w3.org/2001/XMLSchema#string